| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insight Molecular Diagnostics Inc. (IMDX) has 7 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. IMDX is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 12.68M | $65.52M | - | |
| CEO | 400.0K | $2.07M | - | |
| CFO | 201.2K | $1.04M | - | |
| Dir | 136.6K | $705.3K | - | |
| Dir | 39.5K | $204.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 26, 2018 | Levine Mitchell S | Chief Financial Officer | Buy | 3,495 | $0.00 | - | New | |
| Jul 26, 2018 | Hesterberg Lyndal K. | Sr VP, Research &Development | Buy | 874 | $0.00 | - | New | |
| Jul 26, 2018 | Last Andrew J.49 | Director | Buy | 6,993 | $0.00 | - | New | |
| Jul 26, 2018 | Redmond Cavan M. | Director | Buy | 52,447 | $0.00 | - | New | |
| Jul 26, 2018 | Andrews Ronald Asbury | Director | Buy | 17,482 | $0.00 | - | New | |
| Mar 28, 2018 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 3,968,254 | $1.26 | $5,000,000.04 | +35.6% |